Clinical Research Fellow

Overview

Applications are invited for the post of Clinical Research Fellow in the Prostate Cancer Targeted Therapy Group (PCTTG) at the Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. The PCTTG, under the leadership and guidance of Professor Johann de Bono and Drs Adam Sharp and Alec Paschalis, has led on the development of many of the new drugs currently used for the management of advanced prostate cancer including abiraterone, cabazitaxel, enzalutamide, olaparib and Lutetium PSMA.

The Unit is based in Sutton at the Royal Marsden in the Oak Cancer Centre, a day‑care area with outpatient facilities exclusively dedicated to the care and treatment of patients enrolled in clinical trials and is closely linked to our translational research laboratories at The Institute of Cancer Research.

This post is an excellent opportunity to be centrally involved in the management of patients with advanced prostate cancer enrolled in clinical trials of experimental anti‑cancer drugs. In addition, the applicant will be encouraged to become involved in translational research that could lead to a PhD and will gain experience in translational and clinical research including the conduct of clinical trials and manuscript writing.

Applicants must meet the following essential criteria: full registration with the General Medical Council, acquisition of MRCP, and clinical experience in managing cancer patients.

Due to the high volumes of applications we receive, we reserve the right to close any adverts before the published closing date once we have received a sufficient number of applications. Please submit your application as early as possible to prevent disappointment.

We particularly welcome applications from Black, Asian and minority ethnic candidates, LGBTQ+ candidates and candidates with disabilities. As a Disability Confident Employer, we are committed to creating a workplace that enables all staff to reach their full potential.